	Capitaux D'Emprunt		Date
AbbVie	USD 62.97B	12M	2025-09
Acadia Pharmaceuticals	USD 0	0	2025-03
Akebia Therapeutics	USD 47.64M	579K	2025-09
ALKERMES	USD 285.82M	639K	2024-09
Alnylam Pharmaceuticals	USD 1.04B	13.75M	2025-09
Amgen	USD 50B	2.43B	2025-12
Baxter International	USD 9.49B	80M	2025-06
Biogen	USD 6.29B	1.4M	2025-09
BioMarin Pharmaceutical	USD 596.66M	501K	2025-09
Bristol-Myers Squibb	USD 42.85B	1.62B	2025-12
Coherus Biosciences	USD 294.85M	2.33M	2025-03
Eli Lilly	USD 40.87B	6.69B	2025-09
Fujifilm	JPY 642.24B	70.37B	2025-12
Gilead Sciences	USD 22.14B	5M	2025-09
Ironwood Pharmaceuticals	USD 583.99M	14.83M	2024-12
Merck	USD 39.97B	6B	2025-09
Myriad Genetics	USD 119.5M	60.2M	2025-09
Pacira	USD 376.72M	1.37M	2025-09
Perrigo	USD 3.61B	7.4M	2025-09
Pfizer	USD 57.41B	93M	2025-09
PTC Therapeutics	USD 1.84B	298.68M	2025-09
Regeneron Pharmaceuticals	USD 2.71B	720.4M	2025-12
Sarepta Therapeutics	USD 1.04B	104.31M	2025-09
Teva Pharmaceutical Industries	USD 14.99B	1.78B	2025-12
Vertex Pharmaceuticals	USD 111.4M	1.4M	2025-03
Xencor	USD 87.78M	6.96M	2025-09
Zoetis	USD 7.07B	1.84B	2025-09

Coherus Biosciences Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.